– The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with DME treated with Vabysmo who identify as African American, Black, Hispanic and ...

Please provide your email address to receive an email when new articles are posted on . The approval was supported by 1-year results from the phase 3 Pagoda study. Susvimo is also approved for wet age ...

ZUG, Switzerland, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today ...

Resistant diabetic macular edema may necessitate transitioning from one intravitreal pharmacotherapy to another when the edema is persistent — a practice sometimes undertaken in clinical management.

Of those assigned to a 16-week dosing regimen at baseline, 83% maintained ≥16-week dosing intervals through two years Many patients met the extension criteria for even longer dosing intervals, ...

Blurry vision can be an early warning sign of diabetes. It's also a sign of advanced diabetic eye disease. If blood sugar goes uncontrolled, diabetes causes progressive damage to structures in the ...

Many people with diabetes aren’t aware that the condition can affect eyesight. Here’s how to advocate for better care and treatments. “There is a huge lack of knowledge on how diabetes can affect your ...

Diabetic macular edema treatment options include anti-vascular endothelial growth factor (anti-VEGF) injections and laser therapy, with patient-specific factors guiding the best approach. What are the ...

Diabetic retinopathy is an eye condition that causes changes to the blood vessels in the part of your eye called the retina. That's the lining at the back of your eye that changes light into images.